Personalized medicine for innate endotypes in asthma. A schematic view of a sampling strategy, inflammatory measurement, and potential targets for developing actionable individual interventions in asthma. CDKi cyclin-dependent kinase inhibitor, ICS inhaled corticosteroids, SID stable-isotope dilution, SRM-MS selective reaction monitoring mass spectrometry